149 related articles for article (PubMed ID: 15736032)
21. Macrolide, lincosamide and streptogramin B resistance in a dominant clone of Australian community methicillin-resistant Staphylococcus aureus.
O'Brien FG; Zaini Z; Coombs GW; Pearson JC; Christiansen K; Grubb WB
J Antimicrob Chemother; 2005 Nov; 56(5):985-6. PubMed ID: 16204342
[No Abstract] [Full Text] [Related]
22. Community-acquired pneumonia and bacteraemia in a healthy young woman caused by methicillin-resistant Staphylococcus aureus (MRSA) carrying the genes encoding Panton-Valentine leukocidin (PVL).
Torell E; Molin D; Tano E; Ehrenborg C; Ryden C
Scand J Infect Dis; 2005; 37(11-12):902-4. PubMed ID: 16308227
[No Abstract] [Full Text] [Related]
23. Practical management: community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA): the latest sports epidemic.
Benjamin HJ; Nikore V; Takagishi J
Clin J Sport Med; 2007 Sep; 17(5):393-7. PubMed ID: 17873553
[TBL] [Abstract][Full Text] [Related]
24. Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients.
Skiest DJ; Brown K; Cooper TW; Hoffman-Roberts H; Mussa HR; Elliott AC
J Infect; 2007 May; 54(5):427-34. PubMed ID: 17070598
[TBL] [Abstract][Full Text] [Related]
25. Methicillin-resistant staphylococcus aureus infections among competitive sports participants--Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Aug; 52(33):793-5. PubMed ID: 12931079
[TBL] [Abstract][Full Text] [Related]
26. Implications of methicillin-resistant Staphylococcus aureus as a community-acquired pathogen in pediatric patients.
Kaplan SL
Infect Dis Clin North Am; 2005 Sep; 19(3):747-57. PubMed ID: 16102659
[TBL] [Abstract][Full Text] [Related]
27. Perinephric abscess caused by community-acquired methicillin resistant Staphylococcus aureus.
Malik ZA; Litman N
Pediatr Infect Dis J; 2007 Aug; 26(8):764. PubMed ID: 17848900
[No Abstract] [Full Text] [Related]
28. Describing the methicillin-resistant Staphylococcus aureus epidemic: a public health challenge.
Gerber SI
Expert Rev Anti Infect Ther; 2006 Dec; 4(6):905-7. PubMed ID: 17181403
[No Abstract] [Full Text] [Related]
29. Community-acquired methicillin-resistant Staphylococcus aureus: time for action.
Mitchell DH; Chen SC
Pathology; 2006 Jun; 38(3):199-200. PubMed ID: 16753738
[No Abstract] [Full Text] [Related]
30. A clonal expansion of methicillin-resistant Staphylococcus aureus (MRSA) in a tuberculosis ward.
Hosoda M; Toyama J; Hasada K; Fujino T; Ohtsuki R; Kirikae T
Jpn J Infect Dis; 2002 Dec; 55(6):219-21. PubMed ID: 12606837
[No Abstract] [Full Text] [Related]
31. Prevention of health care-associated methicillin-resistant Staphylococcus aureus infections: adapting to a changing epidemiology.
Karchmer TB
Clin Infect Dis; 2005 Jul; 41(2):167-9. PubMed ID: 15983911
[No Abstract] [Full Text] [Related]
32. Understanding the success of methicillin-resistant Staphylococcus aureus strains causing epidemic disease in the community.
Gorwitz RJ
J Infect Dis; 2008 Jan; 197(2):179-82. PubMed ID: 18173362
[No Abstract] [Full Text] [Related]
33. Are MRSA bacteraemias all hospital acquired?
Ferguson CA; Saunders D; Gibb AP
J Hosp Infect; 2005 Oct; 61(2):178-9. PubMed ID: 16009461
[No Abstract] [Full Text] [Related]
34. Pediatric community-acquired methicillin-resistant Staphylococcus aureus infection and colonization: trends and management.
Paintsil E
Curr Opin Pediatr; 2007 Feb; 19(1):75-82. PubMed ID: 17224666
[TBL] [Abstract][Full Text] [Related]
35. Comment on: A survey of community-associated methicillin-resistant Staphylococcus aureus in Korea.
Park C; Lee DG; Choi SM; Choi JH; Park SH; Yoo JH; Shin WS
J Antimicrob Chemother; 2008 Jul; 62(1):211-2; author repply 212-3. PubMed ID: 18385144
[No Abstract] [Full Text] [Related]
36. Antimicrobial resistance in clinical isolates of Staphylococcus aureus from hospital and community sources in southern Jamaica.
Brown PD; Ngeno C
Int J Infect Dis; 2007 May; 11(3):220-5. PubMed ID: 16815064
[TBL] [Abstract][Full Text] [Related]
37. Community-acquired methicillin-resistant Staphylococcus aureus in Madrid, Spain: transcontinental importation and polyclonal emergence of Panton-Valentine leukocidin-positive isolates.
Cercenado E; Cuevas O; Marín M; Bouza E; Trincado P; Boquete T; Padilla B; Vindel A
Diagn Microbiol Infect Dis; 2008 Jun; 61(2):143-9. PubMed ID: 18280081
[TBL] [Abstract][Full Text] [Related]
38. Therapies and vaccines for emerging bacterial infections: learning from methicillin-resistant Staphylococcus aureus.
John CC; Schreiber JR
Pediatr Clin North Am; 2006 Aug; 53(4):699-713. PubMed ID: 16873000
[TBL] [Abstract][Full Text] [Related]
39. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants - Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003.
Conn Med; 2003 Oct; 67(9):549-51. PubMed ID: 14674406
[No Abstract] [Full Text] [Related]
40. Emergence of non-multiresistant methicillin-resistant Staphylococcus aureus as the commonest pathogen causing skin infections in a rural Australian city.
Pandey R
J Infect; 2008 May; 56(5):393-4. PubMed ID: 18359088
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
